{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:09:43Z","timestamp":1778944183635,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["12A3814N"],"award-info":[{"award-number":["12A3814N"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["602300"],"award-info":[{"award-number":["602300"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007660","name":"Universiteit Antwerpen","doi-asserted-by":"publisher","award":["FFB190208"],"award-info":[{"award-number":["FFB190208"]}],"id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11B5220N"],"award-info":[{"award-number":["11B5220N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1S07717N"],"award-info":[{"award-number":["1S07717N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bone.2020.115406","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T04:30:24Z","timestamp":1588825824000},"page":"115406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["A multi-omics approach expands the mutational spectrum of MAP2K1-related melorheostosis"],"prefix":"10.1016","volume":"137","author":[{"given":"Rapha\u00ebl","family":"De Ridder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline","family":"Boudin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Carola","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9728-5273","authenticated-orcid":false,"given":"Joe","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bram C.J.","family":"van der Eerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"Van Hul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9871-4578","authenticated-orcid":false,"given":"Geert","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bone.2020.115406_bb0005","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00223-019-00543-y","article-title":"Melorheostosis and osteopoikilosis: a review of clinical features and pathogenesis","volume":"104","author":"Wordsworth","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2020.115406_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bone.2018.09.005","article-title":"CT analysis of anatomical distribution of melorheostosis challenges the sclerotome hypothesis","volume":"117","author":"Jha","year":"2018","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bone.2020.115406_bb0015","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/ng1453","article-title":"Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis","volume":"36","author":"Hellemans","year":"2004","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.bone.2020.115406_bb0020","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1096-8628(19971003)72:1<43::AID-AJMG9>3.0.CO;2-W","article-title":"Melorheostosis in a patient with familial osteopoikilosis","volume":"72","author":"Butkus","year":"1997","journal-title":"Am. J. Med. Genet."},{"issue":"3","key":"10.1016\/j.bone.2020.115406_bb0025","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/humu.9403","article-title":"Germline LEMD3 mutations are rare in sporadic patients with isolated melorheostosis","volume":"27","author":"Hellemans","year":"2006","journal-title":"Hum. Mutat."},{"issue":"2","key":"10.1016\/j.bone.2020.115406_bb0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1359\/jbmr.061102","article-title":"Deactivating germline mutations in LEMD3 cause osteopoikilosis and Buschke-Ollendorff syndrome, but not sporadic melorheostosis","volume":"22","author":"Mumm","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2020.115406_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bone.2017.04.010","article-title":"Melorheostosis: exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS","volume":"101","author":"Whyte","year":"2017","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2020.115406_bb0040","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41467-018-03720-z","article-title":"Somatic activating mutations in MAP2K1 cause melorheostosis","volume":"9","author":"Kang","year":"2018","journal-title":"Nat. Commun."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2020.115406_bb0045","first-page":"S1","volume":"34","year":"2019","journal-title":"J. Bone Miner. Res."},{"issue":"2","key":"10.1016\/j.bone.2020.115406_bb0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/JME-14-0304","article-title":"Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1","volume":"54","author":"Vandamme","year":"2015","journal-title":"J. Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.bone.2020.115406_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13073-014-0074-6","article-title":"VariantDB: a flexible annotation and filtering portal for next generation sequencing data","volume":"6","author":"Vandeweyer","year":"2014","journal-title":"Genome Med."},{"issue":"2","key":"10.1016\/j.bone.2020.115406_bb0060","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsdottir","year":"2013","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.bone.2020.115406_bb0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bone.2018.02.026","article-title":"A soluble activin type IIA receptor mitigates the loss of femoral neck bone strength and cancellous bone mass in a mouse model of disuse osteopenia","volume":"110","author":"Lodberg","year":"2018","journal-title":"Bone"},{"issue":"43","key":"10.1016\/j.bone.2020.115406_bb0070","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.bone.2020.115406_bb0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"issue":"7022","key":"10.1016\/j.bone.2020.115406_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nature03240","article-title":"Stabilization of microtubule dynamics at anaphase onset promotes chromosome segregation","volume":"433","author":"Higuchi","year":"2005","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bone.2020.115406_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.cr.7290105","article-title":"MAPK signal pathways in the regulation of cell proliferation in mammalian cells","volume":"12","author":"Zhang","year":"2002","journal-title":"Cell Res."},{"key":"10.1016\/j.bone.2020.115406_bb0090","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1741-7015-7-41","article-title":"Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study","volume":"7","author":"Zhang","year":"2009","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.bone.2020.115406_bb0095","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/1078-0432.CCR-14-2124","article-title":"MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking","volume":"21","author":"Arcila","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bone.2020.115406_bb0100","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-17-1452","article-title":"Allele-specific mechanisms of activation of MEK1 mutants determine their properties","volume":"8","author":"Gao","year":"2018","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.bone.2020.115406_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30202-5","article-title":"Intrinsically active MEK variants are differentially regulated by proteinases and phosphatases","volume":"8","author":"Ordan","year":"2018","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bone.2020.115406_bb0110","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/nsmb859","article-title":"Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition","volume":"11","author":"Ohren","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"10","key":"10.1016\/j.bone.2020.115406_bb0115","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/1541-7786.MCR-17-0211","article-title":"BRAF-inhibitor associated MEK mutations increase RAF-dependent and -independent enzymatic activity","volume":"15","author":"Emery","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bone.2020.115406_bb0120","series-title":"Molecular Biology of the Cell","author":"Alberts","year":"2015"},{"issue":"6844","key":"10.1016\/j.bone.2020.115406_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/35085684","article-title":"Cell biology. Cytoskeleton in the cell cycle","volume":"412","author":"Nakaseko","year":"2001","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bone.2020.115406_bb0130","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1080\/15384101.2014.998085","article-title":"Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors","volume":"14","author":"Bendris","year":"2015","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.bone.2020.115406_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ceb.2007.11.005","article-title":"Kinetochore-microtubule interactions: the means to the end","volume":"20","author":"Tanaka","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bone.2020.115406_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-8722-3-8","article-title":"From basic research to clinical development of MEK1\/2 inhibitors for cancer therapy","volume":"3","author":"Fremin","year":"2010","journal-title":"J. Hematol. Oncol."},{"issue":"22","key":"10.1016\/j.bone.2020.115406_bb0145","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.2010.33.2312","article-title":"Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling","volume":"29","author":"Wagle","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"48","key":"10.1016\/j.bone.2020.115406_bb0150","doi-asserted-by":"crossref","first-page":"20411","DOI":"10.1073\/pnas.0905833106","article-title":"MEK1 mutations confer resistance to MEK and B-RAF inhibition","volume":"106","author":"Emery","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220301861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220301861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:13:31Z","timestamp":1778940811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220301861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":30,"alternative-id":["S8756328220301861"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115406","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multi-omics approach expands the mutational spectrum of MAP2K1-related melorheostosis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115406"}}